phosphodiesterase 11A (PDE11A) (N-Term) Peptide
PDE11A
Reactivity: Human
Host: Synthetic
BP, WB
-
- Target See all PDE11A products
- PDE11A (phosphodiesterase 11A (PDE11A))
- Protein Region
- N-Term
- Origin
- Human
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB)
- Sequence
- WAGGSRGDGN LQRRASQKEL RKSFARSKAI HVNRTYDEQV TSRAQEPLSS
- Characteristics
- This is a synthetic peptide designed for use in combination with anti-PDE11A Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
-
- Application Notes
- Optimal working dilution should be determined by the investigator.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Storage
- -20 °C
- Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- PDE11A (phosphodiesterase 11A (PDE11A))
- Background
-
The 3',5'-cyclic nucleotides cAMP and cGMP function as second messengers in a wide variety of signal transduction pathways. 3',5'-cyclic nucleotide phosphodiesterases (PDEs) catalyze the hydrolysis of cAMP and cGMP to the corresponding 5'-monophosphates and provide a mechanism to downregulate cAMP and cGMP signaling. This gene encodes a member of the PDE protein superfamily. Mutations in this gene are a cause of Cushing disease and adrenocortical hyperplasia. Multiple transcript variants encoding different isoforms have been found for this gene.
Alias Symbols: PPNAD2
Protein Size: 933 - Gene ID
- 50940
- NCBI Accession
- NM_001077196, NP_001070664
- UniProt
- Q9HCR9
-
You are here:
